Abstract
Dyskeratosis congenita is a rare hereditary disorder characterized by skin pigmentation, nail dystrophy and leukoplakia along with bone marrow failure and increased predisposition to malignant tumours. Here we describe a 7-year-old child who presented with classic triad of pigmentation, nail changes, leukoplakia along with manifestations of bone marrow failure. He was initially put on androgen therapy with plan for a possible matched related allogenic HSCT. A haematologist should be aware of the complications of therapy, bronchopulmonary complications, futility of IST and dangers of using myeloablative transplant in such a patient.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
